Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention. This study describes the changes in cognitive function associated with coronary artery disease, myocardial infarction, heart failure, atrial fibrillation and heart valve disease.

Dementia 64

Dementia Coronary Artery Disease Quality of Life Myocardial Infarction 64

DAIC

APRIL 6, 2024

The EMPACT-MI trial was designed to determine whether SGLT-2 inhibitors could safely help to prevent heart failure and reduce mortality in people with a high risk of heart failure following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

DAIC

APRIL 6, 2024

The EMPACT-MI trial was designed to determine whether SGLT-2 inhibitors could safely help to prevent heart failure and reduce mortality in people with a high risk of heart failure following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81